on NANOBIOTIX (EPA:NANO)
Nanobiotix Announces Voting Rights and Shares Capital Update
Nanobiotix, a clinical-stage biotechnology company, has released updates concerning its voting rights and shares capital as of July 31, 2025. According to the latest figures, the company currently has 48,236,671 shares outstanding. The total number of theoretical voting rights stands at 50,340,736, while the exercisable voting rights are slightly lower at 50,318,618. This announcement follows the guidelines established by the French Commercial Code and the French Financial Markets Authority.
The company is listed on both Euronext Paris and Nasdaq, under the trading symbols NBTX and NANO.PA respectively. Nanobiotix continues its innovative work in biotechnology, centered around physics-based therapeutic approaches to improve treatment outcomes for patients worldwide.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news